VEXT — Vext Science Balance Sheet
0.000.00%
- CA$61.92m
- CA$105.74m
- $36.00m
- 65
- 88
- 77
- 91
Annual balance sheet for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.75 | 6.47 | 5.93 | 8.72 | 4.62 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19.9 | 24.2 | 22.3 | 8.45 | 1.94 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24 | 31.2 | 51.9 | 41.3 | 26.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.7 | 29 | 36.4 | 41.2 | 39.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 55.5 | 83.7 | 121 | 150 | 137 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.83 | 9.74 | 15.7 | 14 | 17.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 19.1 | 24.3 | 48.6 | 54.6 | 61.2 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 36.3 | 59.4 | 71.9 | 95 | 75.7 |
| Total Liabilities & Shareholders' Equity | 55.5 | 83.7 | 121 | 150 | 137 |
| Total Common Shares Outstanding |